Video
​Fred Massoomi, PharmD, discusses compounding options.
Fred Massoomi, PharmD, discusses compounding options.
FDA Approves Dupilumab, Marking First Targeted Therapy in a Decade for Chronic Spontaneous Urticaria
FDA Approves Dupilumab, Marking First Targeted Therapy in a Decade for Chronic Spontaneous Urticaria
2 Commerce Drive
Cranbury, NJ 08512